Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      FibroGen to Report Second Quarter 2022 Financial Results
      Biotech

      FibroGen to Report Second Quarter 2022 Financial Results

      July 25, 2022
      UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients
      Biotech

      UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients

      July 25, 2022
      Pluri CEO Issues Shareholder Update
      Biotech

      Pluri CEO Issues Shareholder Update

      July 25, 2022
      Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
      Biotech

      Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

      July 25, 2022
      Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
      Biotech

      Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

      July 22, 2022
      Prometheus Biosciences to Host a Virtual R&D Day for Analysts and Investors on July 26, 2022
      Biotech

      Prometheus Biosciences to Host a Virtual R&D Day for Analysts and Investors on July 26, 2022

      July 22, 2022
      Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Biotech

      Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      July 22, 2022
      Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
      Biotech

      Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis

      July 22, 2022
      Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement
      Biotech

      Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement

      July 22, 2022
      Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022
      Biotech

      Vericel to Report Second-Quarter 2022 Financial Results on August 3, 2022

      July 22, 2022
      « 1 … 124 125 126 127 128 … 132 »

       

      LATEST NEWS

      • Investing News Amazon’s Market Challenges Explained
      • Investing News GE HealthCare Stock Outlook: Bullish Signals?
      • Investing News Accenture Stock Outlook: Bullish or Bearish?
      • Investing News Teradyne Stock Forecast: Rise or Reversal?
      • Investing News Qualcomm Stock Dip Buy: Oversold or Opportunity?

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026